Close Menu

The Scientist profiles Aaron Chiechanover, who shared the 2004 Nobel Prize in Chemistry for the discovery of ubiquitin-mediated protein degradation ― a determination he made as part of his PhD thesis. “We didn’t set out to identify ubiquitin. We didn’t know anything about ubiquitin or its function,” Ciechanover tellsThe Scientist. “We were studying intracellular proteolysis and we bumped into it.”

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.